Home

Astrazeneca Pharma India Ltd Quarterly Result

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

Net Profit - Last Quarter

₹ 38.43 Cr.

Last updated on: Jan 15, 2025

Key Highlights

  • The revenue of Astrazeneca Pharma India Ltd for the Sep '24 is ₹ 416.15 crore as compare to the Jun '24 revenue of ₹ 395.87 crore. This represent the growth of 5.122894%.
  • The ebitda of Astrazeneca Pharma India Ltd for the Sep '24 is ₹ 60.69 crore as compare to the Jun '24 ebitda of ₹ -11.14 crore. This represent the decline of -644%.
  • The net profit of Astrazeneca Pharma India Ltd for the Sep '24 is ₹ 38.43 crore as compare to the Jun '24 net profit of ₹ -11.79 crore. This represent the decline of -425%.

Results Analysis

Market Price of Astrazeneca Pharma India Ltd

1M

1Y

3Y

5Y

Monitoring Astrazeneca Pharma India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20257030.35
13 Jan 20257043.7
10 Jan 20256912.5
09 Jan 20257076
08 Jan 20256892.55
07 Jan 20257092.85
06 Jan 20257251.75
03 Jan 20257113.75
02 Jan 20257137.75
01 Jan 20257206.4

Historical Revenue of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical EBITDA of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Net Profit of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Astrazeneca Pharma India Ltd News Hub

AstraZeneca slumps on recording dismal Q1 performance

Revenue from operations jumped 31.15% year on year (YoY) to Rs 387.52 crore in the quarter ended 30

Read more

2024-08-08 00:00:00

Astrazeneca Pharma India reports standalone net loss of Rs 11.79 crore in the June 2024 quarter

Net loss of Astrazeneca Pharma India reported to Rs 11.79 crore in the quarter ended June 2024 as ag

Read more

2024-08-08 00:00:00

Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions

Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed by IMFINZI

Read more

2024-09-24 00:00:00

Astrazeneca Pharma India Ltd leads gainers in 'A' group

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and National Alumini

Read more

2024-09-24 00:00:00

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Astrazeneca Pharma India Ltd

What key financial metrics are included in Astrazeneca Pharma India Ltd's quarterly results?

Key financial metrics in Astrazeneca Pharma India Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Astrazeneca Pharma India Ltd announce its quarterly results?

Astrazeneca Pharma India Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Astrazeneca Pharma India Ltd's quarterly performance impact its stock price?

Astrazeneca Pharma India Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Astrazeneca Pharma India Ltd's quarterly results on dividends?

The impact of Astrazeneca Pharma India Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Astrazeneca Pharma India Ltd's quarterly results?

Yes, Astrazeneca Pharma India Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions